Markforged Holding (MKFG) 10-K/A 14 May 21 2020 FY Annual report (amended) Financial data

Document and Entity Information

Document and Entity Information - USD ($)	6 Months Ended
	Dec. 31, 2020	May 13, 2021	Jun. 30, 2020
Document Type	10-K/A
Document Annual Report	true
Document Transition Report	false
Document Period End Date	Dec. 31, 2020
Entity Registrant Name	one
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	true
Entity Public Float			$ 0
Entity Central Index Key	0001816613
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	FY
Amendment Flag	true
Transition Report	false
Amendment Description	Amendment No.1
Units, each consisting of one Class A ordinary share, $0.0001 par value, and one-fourth of one redeemable warrant
Title of 12(b) Security	Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant
Trading Symbol	AONE.U
Security Exchange Name	NYSE
Class A ordinary shares
Title of 12(b) Security	Class A ordinary shares, par value $0.0001 per share
Trading Symbol	AONE
Security Exchange Name	NYSE
Entity Common Stock, Shares Outstanding		21,500,000
Redeemable warrants, each warrant exercisable for one Class A ordinary share, each at an exercise price of $11.50 per share
Title of 12(b) Security	Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
Trading Symbol	AONE.WS
Security Exchange Name	NYSE
Class B ordinary shares
Entity Common Stock, Shares Outstanding		5,375,000

BALANCE SHEET

BALANCE SHEET	Dec. 31, 2020USD ($)
Current assets:
Cash	$ 919,823
Prepaid expenses	314,351
Total current assets	1,234,174
Investments held in Trust Account	215,076,225
Total Assets	216,310,399
Current liabilities:
Accounts payable	115,360
Accrued expenses	24,847
Total current liabilities	140,207
Deferred underwriting commissions	7,525,000
Derivative warrant liabilities	17,902,500
Total Liabilities	25,567,707
Commitments and Contingencies
Class A ordinary shares, $0.0001 par value; 20,364,519 shares subject to possible redemption at $10.00 per share	185,742,690
Shareholder's Equity:
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding	0
Additional paid-in capital	7,610,730
Accumulated deficit	(2,611,559)
Total shareholders' equity	5,000,002
Total Liabilities and Shareholder's Equity	216,310,399
Class A ordinary shares
Shareholder's Equity:
Common stock	293
Class B ordinary shares
Shareholder's Equity:
Common stock	$ 538

BALANCE SHEET (Parenthetical)

BALANCE SHEET (Parenthetical)	Dec. 31, 2020$ / sharesshares
Preferred stock, par value | $ / shares	$ 0.0001
Preferred stock, shares authorized	1,000,000
Preferred stock, shares issued	0
Preferred stock, shares outstanding	0
Class A ordinary shares, par value | $ / shares	$ 0.0001
Class A ordinary shares, shares subject to possible redemption	18,574,269
Class A ordinary shares, per share | $ / shares	$ 10
Class A ordinary shares
Common stock, par value | $ / shares	$ 0.0001
Common stock, shares authorized	400,000,000
Common stock, shares issued	2,925,731
Common stock, shares outstanding	2,925,731
Class B ordinary shares
Common stock, par value | $ / shares	$ 0.0001
Common stock, shares authorized	10,000,000
Common stock, shares issued	5,375,000
Common stock, shares outstanding	5,375,000

STATEMENT OF OPERATIONS

STATEMENT OF OPERATIONS	6 Months Ended
	Dec. 31, 2020USD ($)$ / sharesshares
General and administrative expenses	$ 340,824
Administrative expenses - related party	40,000
Loss from operations	(380,824)
Other income (expenses)
Change in fair value of derivative warrant liabilities	(1,705,000)
Offering costs associated with derivative warrant liabilities	(601,960)
Net gain from investments held in Trust Account	76,225
Net loss	$ (2,611,559)
Class A ordinary shares
Other income (expenses)
Basic and diluted weighted average shares outstanding | shares	21,500,000
Basic and diluted net income (loss) per share | $ / shares	$ 0
Class B ordinary shares
Other income (expenses)
Basic and diluted weighted average shares outstanding | shares	5,265,873
Basic and diluted net income (loss) per share | $ / shares	$ (0.51)

STATEMENT OF CHANGES IN SHAREHO

STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)	Class A ordinary sharesOrdinary Shares	Class B ordinary sharesOrdinary Shares	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at the beginning at Jun. 23, 2020	$ 0	$ 0	$ 0	$ 0	$ 0
Balance at the beginning (in shares) at Jun. 23, 2020	0	0
Net loss					(792,984)
Balance at the ending at Sep. 30, 2020					5,000,007
Balance at the beginning at Jun. 23, 2020	$ 0	$ 0	0	0	0
Balance at the beginning (in shares) at Jun. 23, 2020	0	0
Issuance of ordinary shares to Sponsor		$ 575	24,425		25,000
Issuance of ordinary shares to Sponsor (in shares)		5,750,000
Sale of units in initial public offering, less fair value of public warrants	$ 2,150		204,785,350		204,787,500
Sale of units in initial public offering, less fair value of public warrants (in shares)	21,500,000
Offering costs			(11,773,249)		(11,773,249)
Excess of cash received over fair value of private placement warrants			315,000		315,000
Forfeiture of Class B ordinary shares		$ (37)	37
Forfeiture of Class B ordinary shares (in shares)		(375,000)
Shares subject to possible redemption	$ (1,857)		(185,740,833)		(185,742,690)
Shares subject to possible redemption (in shares)	(18,574,269)
Net loss				(2,611,559)	(2,611,559)
Balance at the ending at Dec. 31, 2020	$ 293	$ 538	$ 7,610,730	$ (2,611,559)	$ 5,000,002
Balance at the ending (in shares) at Dec. 31, 2020	2,925,731	5,375,000

STATEMENT OF CASH FLOWS

STATEMENT OF CASH FLOWS - USD ($)	3 Months Ended	6 Months Ended
	Sep. 30, 2020	Dec. 31, 2020
Cash Flows from Operating Activities:
Net loss		$ (2,611,559)
Adjustments to reconcile net loss to net cash used in operating activities:
General and administrative expenses paid by related party under note payable		25,000
Change in fair value of derivative warrant liabilities		1,705,000
Offering costs associated with derivative warrant liabilities	$ 601,960	601,960
Net gain from investments held in Trust Account	(9,978)	(76,225)
Changes in operating assets and liabilities:
Prepaid expenses		(314,351)
Accounts payable		30,360
Accrued expenses		24,847
Net cash used in operating activities	(393,915)	(614,968)
Cash Flows from Investing Activities:
Cash deposited in Trust Account		(215,000,000)
Net cash used in investing activities	(215,000,000)	(215,000,000)
Cash Flows from Financing Activities:
Proceeds from note payable to related parties		65,000
Repayment of note payable to related parties		(162,854)
Proceeds received from initial public offering, gross		215,000,000
Proceeds received from private placement		6,300,000
Offering costs paid		(4,667,355)
Net cash provided by financing activities	216,459,791	216,534,791
Net change in cash	1,065,876	919,823
Cash - beginning of the period	$ 0	0
Cash - ending of the period		919,823
Supplemental disclosure of non-cash investing and financing activities:
Offering costs paid in exchange for issuance of Class B ordinary shares to Sponsor		25,000
Offering costs included in accounts payable		85,000
Offering costs included in note payable - related party		72,854
Deferred underwriting commissions		7,525,000
Initial value of Class A Ordinary shares subject to possible redemption		187,650,100
Change in value of Class A ordinary shares subject to possible redemption		$ (1,907,410)

DESCRIPTION OF ORGANIZATION, BU

DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS	6 Months Ended
	Dec. 31, 2020
DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS
DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS	NOTE 1. DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS Organization and General One (the “Company”) is a newly incorporated blank check company incorporated in the Cayman Islands on June 24, 2020. The Company was incorporated for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart our Business Startups Act of 2012 (the “JOBS Act”). At December 31, 2020, the Company had not yet commenced operations. All activity for the period from June 24, 2020 (inception) through December 31, 2020 relates to the Company’s formation and its preparation for the initial public offering (“Initial Public Offering”), which is described below, and since the offering, the search for a prospective initial Business Combination. The Company will not generate any operating revenue until after the completion of its initial Business Combination, at the earliest. The Company generates non-operating income in the form of income earned on investments on cash and cash equivalents in the Trust Account (as defined below). The Company has selected December 31 as its fiscal year end. The Company’s sponsor is A-star, a Cayman Islands exempted limited partnership (“Sponsor”). The registration statement for the Company’s Initial Public Offering was declared effective on August 17, 2020. On August 20, 2020, the Company consummated its Initial Public Offering of 21,500,000 units (the “Units” and, with respect to the Class A ordinary shares included in the Units being offered, the “Public Shares”), including 1,500,000 additional Units to cover over-allotments (the “Over-Allotment Units”), at $10.00 per Unit, generating gross proceeds of $215.0 million, and incurring offering costs of approximately $12.4 million, inclusive of approximately $7.5 million in deferred underwriting commissions (Note 6). Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement (“Private Placement”) of 3,150,000 warrants (each, a “Private Placement Warrant” and collectively, the “Private Placement Warrants”), at a price of $2.00 per Private Placement Warrant with the Sponsor, generating gross proceeds of approximately $6.3 million (Note 5). Upon the closing of the Initial Public Offering and the Private Placement, $215.0 million ($10.00 per Unit) of the net proceeds of the Initial Public Offering and certain of the proceeds of the Private Placement were placed in a trust account (“Trust Account”), located in the United States, with Continental Stock Transfer & Trust Company acting as trustee, and will be invested by the trustee only in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a‑7 of the Investment Company Act, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below. The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete one or more initial Business Combinations having an aggregate fair market value of at least 80% of the assets held in the Trust Account (as defined below) (excluding the deferred underwriting commissions and taxes payable on income earned on the Trust Account) at the time of the agreement to enter into the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). The Company will provide its holders (the “Public Shareholders”) of its Public Shares with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a general meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.00 per Public Share). The per-share amount to be distributed to Public Shareholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 6). These Public Shares have been recorded at a redemption value and classified as temporary equity upon the completion of the Initial Public Offering, in accordance with Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and a majority of the shares voted are voted in favor of the Business Combination. If a shareholder vote is not required by law and the Company does not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Memorandum and Articles of Association (the “Amended and Restated Memorandum and Articles of Association”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, shareholder approval of the transactions is required by law, or the Company decides to obtain shareholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each Public Shareholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction. If the Company seeks shareholder approval in connection with a Business Combination, the initial shareholders (as defined below) have agreed to vote their Founder Shares (as defined below in Note 5) and any Public Shares purchased during or after the Initial Public Offering in favor of a Business Combination. Subsequent to the consummation of the Initial Public Offering, the Company will adopt an insider trading policy which will require insiders to: (i) refrain from purchasing shares during certain blackout periods and when they are in possession of any material non-public information and (ii) to clear all trades with the Company’s legal counsel prior to execution. In addition, the initial shareholders have agreed to waive their redemption rights with respect to their Founder Shares and Public Shares in connection with the completion of a Business Combination. Notwithstanding the foregoing, the Company’s Amended and Restated Memorandum and Articles of Association provides that a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the Class A ordinary shares sold in the Initial Public Offering, without the prior consent of the Company. The Company’s Sponsor, officers and directors (the “Initial Shareholders”) have agreed not to propose an amendment to the amended and restated memorandum and articles of association (a) that would modify the substance or timing of the Company’s obligation to redeem 100% of its Public Shares if the Company does not complete a Business Combination within 24 months from the closing of the Initial Public Offering, or August 20, 2022 (the “Combination Period”) or (b) with respect to any other provision relating to shareholders’ rights or pre-initial Business Combination activity, unless the Company provides the Public Shareholders with the opportunity to redeem their Class A ordinary shares in conjunction with any such amendment. If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest (which interest shall be net of taxes payable and up to $100,000 of interest to pay dissolution expenses), divided by the number of then issued and outstanding Public Shares, which redemption will completely extinguish Public Shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any) and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining shareholders and the Company’s board of directors, liquidate and dissolve, subject, in the case of clauses (ii) and (iii), to the Company’s obligations under Cayman Islands law to provide for claims of creditors and in all cases subject to the other requirements of applicable law. The Sponsor, officers and directors have agreed to waive their liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Sponsor or members of the Company’s management team acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to its deferred underwriting commission (see Note 6) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only $10.00 per share initially held in the Trust Account. In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account. This liability will not apply with respect to any claims by a third party who executed a waiver of any right, title, interest or claim of any kind in or to any monies held in the Trust Account or to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except for the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. Proposed Transaction As more fully described in Note 11, on February 23, 2021, the Company entered into an Agreement and Plan of Merger (the “ Merger Agreement ”), by and among the Company, Caspian Merger Sub Inc., a Delaware corporation and direct, wholly owned subsidiary of the Company (“ Merger Sub ”), and MarkForged, Inc., a Delaware corporation (“ Markforged ”). Also, in connection with Merger Agreement, the Company entered into certain related agreements including Subscription Agreements, Sponsor Support Agreement, Shareholder Support Agreement. For more information, the Company’s announcement and the related agreements have been filed on a Current Report on Form 8‑K on February 24, 2021. Liquidity and Capital Resources As of December 31, 2020, the Company had approximately $0.9 million in its operating bank account and working capital of approximately $1.1 million. The Company’s liquidity needs up to December 31, 2020 had been satisfied through the payment of $25,000 from the Sponsor to cover for certain expenses on behalf of the Company in exchange for the issuance of the Founder Shares, the loan of approximately $163,000 from the Sponsor pursuant to the Note (see Note 5), and the proceeds from the consummation of the Private Placement not held in the Trust Account. The Company fully repaid the Note on August 20, 2020. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (see Note 5). As of December 31, 2020, there were no amounts outstanding under any Working Capital Loan. Based on the foregoing, management believes that the Company will have sufficient working capital and borrowing capacity to meet its needs through the earlier of the consummation of a Business Combination or one year from this filing. Over this time period, the Company will be using these funds for paying existing accounts payable, identifying and evaluating prospective Initial Business Combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the Business Combination.

RESTATEMENT OF PREVIOUSLY ISSUE

RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS	6 Months Ended
	Dec. 31, 2020
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS	NOTE 2 —RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS In May, the Audit Committee of the Company, in consultation with management, concluded that, because of a misapplication of the accounting guidance related to its public and private placement warrants to purchase Class A ordinary shares that the Company issued in August 2020 (the “Warrants”), the Company’s previously issued financial statements for the Affected Periods should no longer be relied upon. As such, the Company is restating its financial statements for the Affected Periods included in this Annual Report. On April 12, 2021, the staff of the Securities and Exchange Commission (the “SEC Staff”) issued a public statement entitled “Staff Statement on Accounting and Reporting Considerations for Warrants issued by Special Purpose Acquisition Companies (“SPACs”)” (the “SEC Staff Statement”). In the SEC Staff Statement, the SEC Staff expressed its view that certain terms and conditions common to SPAC warrants may require the warrants to be classified as liabilities on the SPAC’s balance sheet as opposed to equity. Since issuance on August 20, 2020, the Company’s warrants were accounted for as equity within the Company’s previously reported balance sheets. After discussion and evaluation, including with the Company’s independent registered public accounting firm and the Company’s audit committee, management concluded that the warrants should be presented as liabilities with subsequent fair value remeasurement. Historically, the Warrants were reflected as a component of equity as opposed to liabilities on the balance sheets and the statements of operations did not include the subsequent non-cash changes in estimated fair value of the Warrants, based on our application of FASB ASC Topic 815-40, Derivatives and Hedging, Contracts in Entity’s Own Equity (“ASC 815-40). The views expressed in the SEC Staff Statement were not consistent with the Company’s historical interpretation of the specific provisions within its warrant agreement and the Company’s application of ASC 815-40 to the warrant agreement. The Company reassessed its accounting for Warrants issued on August 20, 2020, in light of the SEC Staff’s published views. Based on this reassessment, management determined that the Warrants should be classified as liabilities measured at fair value upon issuance, with subsequent changes in fair value reported in the Company Statement of Operations each reporting period. Impact of the Restatement The impact of the restatement on the balance sheets, statements of operations and statements of cash flows for the Affected Periods is presented below. The restatement had no impact on net cash flows from operating, investing or financing activities. As of December 31, 2020 As Previously Restatement Reported Adjustment As Restated Balance Sheet Total assets $ 216,310,399 $ — $ 216,310,399 Liabilities and shareholders’ equity Total current liabilities $ 140,207 $ — $ 140,207 Deferred legal fees — — Deferred underwriting commissions 7,525,000 — 7,525,000 Derivative warrant liabilities — 17,902,500 17,902,500 Total liabilities 7,665,207 17,902,500 25,567,707 Class A ordinary shares, $0.0001 par value; shares subject to possible redemption 203,645,190 (17,902,500) 185,742,690 Shareholders’ equity Preference shares - $0.0001 par value — — — Class A ordinary shares - $0.0001 par value 114 179 293 Class B ordinary shares - $0.0001 par value 538 — 538 Additional paid-in-capital 5,303,949 2,306,781 7,610,730 Accumulated deficit (304,599) (2,306,960) (2,611,559) Total shareholders’ equity 5,000,002 — 5,000,002 Total liabilities and shareholders’ equity $ 216,310,399 $ — $ 216,310,399 Period From June 24, 2020 (Inception) Through December 31, 2020 As Previously Restatement Reported Adjustment As Restated Statement of Operations Loss from operations $ (380,824) $ — $ (380,824) Other (expense) income: Change in fair value of derivative warrant liabilities — (1,705,000) (1,705,000) Offering costs associated with derivative warrant liabilities — (601,960) (601,960) Net gain from investments held in Trust Account 76,225 — 76,225 Total other (expense) income 76,225 (2,306,960) (2,230,735) Net loss $ (304,599) $ (2,306,960) $ (2,611,559) Basic and Diluted weighted-average Class A ordinary shares outstanding 21,500,000 — 21,500,000 Basic and Diluted net loss per Class A share $ — $ Basic and Diluted weighted-average Class B ordinary shares outstanding 5,265,873 — 5,265,873 Basic and Diluted net loss per Class B share $ (0.07) — $ (0.51) Period From June 24, 2020 (Inception) Through December 31, 2020 As Previously Restatement Reported Adjustment As Restated Statement of Cash Flows Net loss $ (304,599) $ (2,306,960) $ (2,611,559) Change in fair value of derivative warrant liabilities — 1,705,000 1,705,000 Offering costs associated with derivative warrant liabilities — 601,960 601,960 Net cash used in operating activities (614,968) — (614,968) Net cash used in investing activities (215,000,000) — (215,000,000) Net cash provided by financing activities 216,534,791 — 216,534,791 Net change in cash $ 919,823 $ — $ 919,823 In addition, the impact to the balance sheet dated August 20, 2020, filed on Form 8-K on August 26, 2020 related to the impact of accounting for the public and private warrants as liabilities at fair value resulted in an $16.2 million increase to the derivative warrant liabilities line item at August 20, 2020 and offsetting decrease to the Class A ordinary shares subject to possible redemption mezzanine equity line item. There is no change to total shareholders’ equity at the reported balance sheet date. As of September 30, 2020 As Previously Restatement Reported Adjustment As Restated Balance Sheet Total assets $ 216,445,723 $ — $ 216,445,723 Liabilities and shareholders’ equity Total current liabilities $ 161,956 $ — $ 161,956 Deferred legal fees — Deferred underwriting commissions 7,525,000 — 7,525,000 Derivative warrant liabilities — 16,197,500 16,197,500 Total liabilities 7,686,956 16,197,500 23,884,456 Class A ordinary shares, $0.0001 par value; shares subject to possible redemption 203,758,760 (16,197,500) 187,561,260 Shareholders’ equity Preference shares - $0.0001 par value — — — Class A ordinary shares - $0.0001 par value 112 162 274 Class B ordinary shares - $0.0001 par value 538 — 538 Additional paid-in-capital 5,190,381 601,798 5,792,179 Accumulated deficit (191,024) (601,960) (792,984) Total shareholders’ equity 5,000,007 — 5,000,007 Total liabilities and shareholders’ equity $ 216,445,723 $ — $ 216,445,723

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	6 Months Ended
	Dec. 31, 2020
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of presentation The accompanying financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for financial information and pursuant to the rules and regulations of the SEC. As described in Note 2—Restatement of Previously Issued Financial Statements and Note 10 – Quarterly Financial Information (unaudited), the Company’s financial statements for the period from June 24, 2020 (inception) through December 31, 2020, and for the unaudited interim periods ended September 30, 2020 (collectively, the “Affected Periods”), are restated in this Annual Report on Form 10-K/A (Amendment No. 1) (this “Annual Report”) to correct the misapplication of accounting guidance related to the Company’s warrants in the Company’s previously issued audited and unaudited condensed financial statements for such periods. The restated financial statements are indicated as “Restated” in the audited and unaudited condensed financial statements and accompanying notes, as applicable. See Note 2—Restatement of Previously Issued Financial Statements for further discussion. Emerging growth company As an emerging growth company, the Company may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statement with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Concentration of credit risk Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal depository insurance coverage of $250,000, and investments held in Trust Account. At December 31, 2020, the Company had not experienced losses on this account and management believes the Company is not exposed to significant risks on such account. Investments Held in the Trust Account The Company’s portfolio of investments held in the Trust Account is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities, or a combination thereof. The Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in net gain from investments held in Trust Account in the accompanying statement of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. Fair Value of Financial Instruments Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. U.S. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: · Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; · Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and · Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. As of December 31, 2020, the carrying values of cash, prepaid expenses, accounts payable and accrued expenses, which qualify as financial instruments under the FASB ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the balance sheet. The Company’s investments held in Trust Account are comprised of investments in U.S. Treasury securities with an original maturity of 185 days or less or investments in a money market funds that comprise only U.S. Treasury securities and are recognized at fair value. The fair value of investments held in Trust Account is determined using quoted prices in active markets. Use of estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. There were no cash equivalents at December 31, 2020. Offering costs associated with Initial Public Offering The Company complied with the requirements of the ASC 340-10-S99-1. Offering costs consist legal, accounting, underwriting fees and other incremental costs directly attributable to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with warrant liabilities are expensed as incurred, presented as non-operating expenses in the statement of operations. Offering costs associated with the Public Shares were charged to shareholders’ equity upon the completion of the Initial Public Offering. Derivative Warrant liabilities The Company does not use derivative instruments to hedge its exposures to cash flow, market, or foreign currency risks. Management evaluates all of the Company’s financial instruments, including issued warrants to purchase its Class A ordinary shares, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and ASC 815-15. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. The Company issued 5,375,000 warrants to purchase Class A ordinary shares to investors in the Company’s Initial Public Offering and simultaneously issued 3,150,000 Private Placement Warrants. All of the Company’s outstanding warrants are recognized as derivative liabilities in accordance with ASC 815-40. Accordingly, we recognize the warrant instruments as liabilities at fair value and adjust the instruments to fair value at each reporting period. The liabilities are subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in our statement of operations. The fair value of the Public Warrants issued in connection with the Public Offering and Private Placement Warrants were initially measured at fair value using a Binomial Lattice in a risk-neutral framework. For each modeled future price, the warrant payoff is calculated based on the contractual terms (incorporating any optimal early exercise / redemption), and then discounted at the term-matched risk-free rate. Finally, the value of the warrants is calculated as the probability-weighted present value over all future modeled payoffs. The fair value of Public Warrants subsequently been measured based on the listed market price of such warrants while the fair value of the Private Placement Warrants continue to be estimated using a Binomial Lattice model. Class A Ordinary Shares subject to possible redemption The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Shares of Class A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Shares of conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, shares of Class A ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, at December 31, 2020, 18,574,269 shares of Class A ordinary shares subject to possible redemption are presented as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheets. Net income (loss) per ordinary share The Company complies with accounting and disclosure requirements of ASC Topic 260, “Earnings Per Share.” Net loss per share is computed by dividing net loss by the weighted average number of ordinary shares outstanding during the period. The Company has not considered the effect of the warrants sold in the Initial Public Offering and Private Placement to purchase an aggregate of 8,525,000 shares of Class A ordinary shares in the calculation of diluted earnings per share, since their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted loss per ordinary share is the same as basic loss per ordinary share for the periods presented. The Company’s statement of operations includes a presentation of income per share for ordinary share subject to redemption in a manner similar to the two-class method of income per share. Net income per share, basic and diluted for Class A ordinary shares is calculated by dividing the investment income earned on the Trust Account of approximately $76,000 for the period from June 24, 2020 (inception) to December 31, 2020, by the weighted average number of shares of Class A ordinary shares outstanding for the period. Net loss per share, basic and diluted for Class B ordinary shares is calculated by dividing the net loss of approximately $2.6 million, less income attributable to Class A ordinary shares, by the weighted average number of shares of Class B ordinary shares outstanding for the period. Income taxes ASC Topic 740, “Income Taxes” prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts for interest and penalties as of December 31, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman federal income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. Recent accounting pronouncements Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements.

INITIAL PUBLIC OFFERING

INITIAL PUBLIC OFFERING	6 Months Ended
	Dec. 31, 2020
INITIAL PUBLIC OFFERING
INITIAL PUBLIC OFFERING	NOTE 4. INITIAL PUBLIC OFFERING On August 20, 2020, the Company consummated its Initial Public Offering of 21,500,000 Units, including 1,500,000 Over-Allotment Units, at $10.00 per Unit, generating gross proceeds of $215.0 million, and consummated the simultaneous private placement of 3,150,000 Private Placement Warrants to the Sponsor, at a price of $2.00 per Private Placement Warrant, generating gross proceeds of $6.3 million, incurring offering costs of approximately $12.4 million, inclusive of approximately $7.5 million in deferred underwriting commissions. The Company deposited $215.0 million of the net proceeds in the Trust Account, of which $7.5 million in the aggregate will be payable to the underwriters for deferred underwriting commissions. Each Unit consists of one Class A ordinary share, and one-fourth of one redeemable warrant (each, a “Public Warrant”). Each Public Warrant entitles the holder to purchase one Class A ordinary shares at a price of $11.50 per share, subject to adjustment (see Note 7).

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	6 Months Ended
	Dec. 31, 2020
RELATED PARTY TRANSACTIONS
RELATED PARTY TRANSACTIONS	NOTE 5. RELATED PARTY TRANSACTIONS Founder Shares On June 26, 2020, the Sponsor paid $25,000, or approximately $0.004 per share, to cover certain offering costs in consideration for 5,750,000 Class B ordinary shares, par value $0.0001 (the “Founder Shares”). Up to 750,000 Founder Shares were subject to forfeiture to the extent that the over-allotment option is not exercised in full by the underwriters, so that the Founder Shares would represent 20.0% of the Company’s issued and outstanding shares after the Initial Public Offering. On August 10, 2020, the Sponsor transferred 25,000 Founder Shares to each of Michelle Gill, Lachy Groom, Gautam Gupta, Trina Spear, and Laura de Petra, and 30,000 Founder Shares to Pierre Lamond. On August 20, 2020, the underwriters exercised their over-allotment option and, an aggregate of 375,000 Founder Shares were forfeited by the Sponsor for no consideration accordingly. The initial shareholders agreed, subject to limited exceptions, not to transfer, assign or sell any of their Founder Shares until the earlier to occur of: (A) one year after the completion of the initial Business Combination and (B) subsequent to the initial Business Combination, (x) if the closing price of Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share splits, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30‑ trading day period commencing at least 150 days after the initial Business Combination, or (y) the date on which the Company completes a liquidation, merger, share exchange, reorganization or other similar transaction that results in all of the Public Shareholders having the right to exchange their ordinary shares for cash, securities or other property. Private Placement Warrants Simultaneously with the closing of the Initial Public Offering, the Company consummated the Private Placement of 3,150,000 Private Placement Warrants at a price of $2.00 per Private Placement Warrant with the Sponsor, generating gross proceeds of approximately $6.3 million. Each warrant is exercisable to purchase one Class A ordinary share at $11.50 per share. A portion of the proceeds from the Private Placement Warrants was added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the Private Placement Warrants will expire worthless. The Sponsor and the Company’s officers and directors agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Warrants until 30 days after the completion of the Initial Business Combination. Sponsor Loan On June 26, 2020, the Sponsor agreed to loan the Company up to $300,000 to cover expenses related to the Initial Public Offering pursuant to a promissory note (the “Note”). This loan was non-interest bearing and payable on the earlier of December 31, 2020 or the completion of the Initial Public Offering. The Company borrowed approximately $163,000 under the Note, and fully repaid the Note on August 20, 2020. Working Capital Loans In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1.5 million of such Working Capital Loans may be convertible into private placement warrants at a price of $2.00 per warrant. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. To date, the Company had no borrowings under the Working Capital Loans. Administrative Support Agreement The Company agreed to pay the Sponsor a total of $10,000 per month, commencing on date the Company’s securities are first listed on the New York Stock Exchange (the “listing date”), for office space, secretarial and administrative services. Upon completion of the Initial Business Combination or the Company’s liquidation, the Company will cease paying these monthly fees. The Company incurred $40,000 for expenses in connection with the Administrative Support Agreement from the listing date through December 31, 2020.

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	6 Months Ended
	Dec. 31, 2020
COMMITMENTS AND CONTINGENCIES
COMMITMENTS AND CONTINGENCIES	NOTE 6. COMMITMENTS AND CONTINGENCIES Registration and Shareholder Rights The holders of Founder Shares, Private Placement Warrants, Class A ordinary shares underlying the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans, if any, were entitled to registration rights pursuant to a registration rights agreement. These holders are entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, these holders will have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of the initial Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The Company granted the underwriters a 45‑day option from the final prospectus relating to the Initial Public Offering to purchase up to 1,500,000 additional Units to cover over-allotments, if any, at the Initial Public Offering price less the underwriting discounts and commissions. On August 20, 2020, the underwriters exercised their over-allotment option of 1,500,000 Units and, an aggregate of 375,000 Class B ordinary shares were forfeited by the Sponsor for no consideration accordingly. The underwriters were entitled to an underwriting discount of $0.20 per unit, or $4.3 million in the aggregate, paid upon the closing of the Initial Public Offering. In addition, $0.35 per unit, or approximately $7.5 million in the aggregate will be payable to the underwriters for deferred underwriting commissions. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. Risks and Uncertainties Management continues to evaluate the impact of the COVID‑19 pandemic and has concluded that, while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations, and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statement. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

DERIVATIVE WARRANT LIABILITIES

DERIVATIVE WARRANT LIABILITIES	6 Months Ended
	Dec. 31, 2020
DERIVATIVE WARRANT LIABILITIES
DERIVATIVE WARRANT LIABILITIES	NOTE 7. DERIVATIVE WARRANT LIABILITIES As of December 31, 2020, the Company has 5,375,000 and 3,150,000 Public Warrants and Private Placement Warrants, respectively, outstanding. Public Warrants may only be exercised for a whole number of shares. No fractional Public Warrants will be issued upon separation of the Units and only whole Public Warrants will trade. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination or (b) 12 months from the closing of the Initial Public Offering; provided in each case that the Company has an effective registration statement under the Securities Act covering the Class A ordinary shares issuable upon exercise of the warrants and a current prospectus relating to them is available (or the Company permits holders to exercise their warrants on a cashless basis and such cashless exercise is exempt from registration under the Securities Act). The Company has agreed that as soon as practicable, but in no event later than 20 business days after the closing of the initial Business Combination, the Company will use its commercially reasonable efforts to file with the SEC a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants, and the Company will use its commercially reasonable efforts to cause the same to become effective within 60 business days after the closing of the initial Business Combination, and to maintain the effectiveness of such registration statement and a current prospectus relating to those Class A ordinary shares until the warrants expire or are redeemed; provided that if the Class A ordinary shares are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elect, it will not be required to file or maintain in effect a registration statement. If a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants is not effective by the 60th day after the closing of the initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption, but the Company will use its best efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. The warrants have an exercise price of at $11.50 per share and will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. The exercise price and number of ordinary shares issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. In addition, if(x) the Company issues additional Class A ordinary shares or equity linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per Class A ordinary share (with such issue price or effective issue price to be determined in good faith by the board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance), or the Newly Issued Price, (y) the aggregate gross proceeds from such issuances represent more than 50% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of Class A ordinary shares during the 20 trading day period starting on the trading day after the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price described below will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price. The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants and the ordinary shares issuable upon exercise of the Private Placement Warrants, so long as they are held by the Sponsor or its permitted transferees, (i) will not be redeemable by the Company, (ii) may not (including the Class A ordinary shares issuable upon exercise of these warrants), subject to certain limited exceptions, be transferred, assigned or sold by the holders until 30 days after the completion of the initial Business Combination, (iii) may be exercised by the holders on a cashless basis and (iv) will be entitled to registration rights. If the Private Placement Warrants are held by holders other than the Sponsor or its permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by the holders on the same basis as the Public Warrants. Once the warrants become exercisable, the Company may redeem the outstanding warrants (except with respect to the Private Placement Warrants): · in whole and not in part; · at a price of $0.01 per warrant; · upon a minimum of 30 days’ prior written notice of redemption; and · if, and only if, the last reported sales price (the “closing price”) of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for share splits, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders. In addition, commencing ninety days after the warrants become exercisable, the Company may redeem the warrants: · in whole and not in part; · at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to an agreed table based on the redemption date and the “fair market value” of the Class A ordinary shares (as defined below); · if, and only if, the closing price of the Class A ordinary shares equals or exceeds $10.00 per Public Share (as adjusted per share subdivisions, share dividends, reorganizations, recapitalizations and the like) on the trading day before the Company sends the notice of redemption to the warrant holders; · if, and only if, the Private Placement Warrants are also concurrently called for redemption on the same terms as the outstanding Public Warrants, as described above; and · if, and only if, there is an effective registration statement covering the issuance of the Class A ordinary shares issuable upon exercise of the warrants and a current prospectus relating thereto available throughout the 30-day period after written notice of redemption is given. The “fair market value” of the Class A ordinary shares shall mean the volume weighted average price of the Class A ordinary shares as reported during the 10 trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of warrants. If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. Additionally, in no event will the Company be required to net cash settle any Warrants. If the Company is unable to complete the initial Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.

SHAREHOLDERS' EQUITY

SHAREHOLDERS' EQUITY	6 Months Ended
	Dec. 31, 2020
SHAREHOLDERS' EQUITY
SHAREHOLDERS' EQUITY	NOTE 8. SHAREHOLDERS’ EQUITY Preference Shares — The Company is authorized to issue 1,000,000 preference with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of December 31, 2020, there were no preference shares issued or outstanding. Class A Ordinary Shares — The Company is authorized to issue 400,000,000 Class A ordinary shares with a par value of $0.0001 per share. As of December 31, 2020, there were 21,500,000 Class A ordinary shares issued or outstanding, including 20,364,519 Class A ordinary shares subject to possible redemption. Class B Ordinary Shares — The Company is authorized to issue 10,000,000 Class B ordinary shares with a par value of $0.0001 per share. Holders are entitled to one vote for each share of Class B ordinary shares. At August 20, 2020, there were 5,750,000 Class B ordinary shares issued and outstanding, of which an aggregate of up to 750,000 shares were subject to forfeiture to the Company for no consideration to the extent that the underwriters’ over-allotment option is not exercised in full or in part, so that the initial shareholders would collectively own 20% of the Company’s issued and outstanding ordinary shares after the Initial Public Offering. On August 20, 2020, the underwriters exercised their over-allotment option in part and, accordingly, an aggregate of 375,000 Founder Shares were forfeited by the Sponsor for no consideration accordingly. As of December 31, 2020, there were 5,375,000 Class B ordinary shares outstanding. Holders of the Class A ordinary shares and holders of the Class B ordinary shares will vote together as a single class on all matters submitted to a vote of the Company’s shareholders, except as required by law or stock exchange rule; provided that only holders of the Class B ordinary shares have the right to vote on the election of the Company’s directors prior to the initial Business Combination. The Class B ordinary shares will automatically convert into Class A ordinary shares immediately upon the consummation of the initial Business Combination at a ratio such that the number of Class A ordinary shares issuable upon conversion of all Founder Shares will equal, in the aggregate, on an as-converted basis, 20% of the sum of (i) the total number of ordinary shares issued and outstanding upon completion of the Initial Public Offering, plus (ii) the sum of the total number of Class A ordinary shares issued or deemed issued or issuable upon conversion or exercise of any equity- linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial Business Combination, excluding any Class A ordinary shares or equity- linked securities exercisable for or convertible into Class A ordinary shares issued, deemed issued, or to be issued, to any seller in the initial Business Combination and any Private Placement Warrants that may be issued upon conversion of Working Capital Loans. In no event will the Class B ordinary shares convert into Class A ordinary shares at a rate of less than one to one.

FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS	6 Months Ended
	Dec. 31, 2020
FAIR VALUE MEASUREMENTS
FAIR VALUE MEASUREMENTS	NOTE 9. FAIR VALUE MEASURMENTS The following table presents information about the Company’s financial assets that are measured at fair value on a recurring basis as of December 31, 2020 by level within the fair value hierarchy: Quoted Prices in Significant Other Significant Other Active Markets Observable Inputs Unobservable Inputs Description (Level 1) (Level 2) (Level 3) Assets: Investments held in Trust Account $ 215,076,225 $ — $ — Liabilities: Derivative warrant liabilities - Public $ 11,287,500 $ — $ — Derivative warrant liabilities - Private $ — $ — $ 6,615,000 Transfers to/from Levels 1, 2, and 3 are recognized at the end of the reporting period. The estimated fair value of the Public Warrants transferred from a Level 3 measurement to a Level 1 fair value measurement in October 2020, when the Public Warrants were separately listed and traded. The fair value of the Public Warrants issued in connection with the Public Offering and Private Placement Warrants were initially measured at fair value using a Binomial Lattice model and subsequently, the fair value of the Private Placement Warrants have been estimated using a Binomial Lattice model each measurement date. The fair value of Public Warrants issued in connection with the Initial Public Offering have been measured based on the listed market price of such warrants, a Level 1 measurement, since October 2020. For the period ended December 31, 2020, the Company recognized a charge to the statement of operations resulting from an increase in the fair value of liabilities of approximately $1.7 million presented as change in fair value of derivative warrant liabilities on the accompanying statement of operations. The estimated fair value of the Private Placement Warrants, and the Public Warrants prior to being separately listed and traded, is determined using Level 3 inputs. Inherent in a Binomial Lattice model are assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the expected volatility of its Class A ordinary share warrants based on the implied volatility from the Company’s traded warrants and from historical volatility of select peer company’s Class A ordinary shares that matches the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates remaining at zero. The following table provides quantitative information regarding Level 3 fair value measurements inputs at December 31, 2020: As of August 20, 2020 As of December 31, 2020 Volatility 45.0 % 25.8 % Stock price n/a $10.77 Risk-free rate 0.35 % 0.43 % Dividend yield % % The change in the fair value of Level 3 fair value measurements for the period from June 24, 2020 (inception) through December 31, 2020 is summarized as follows: Level 3 Derivative warrant liabilities at June 24, 2020 (inception) $ — Issuance of Public and Private Warrants 16,197,500 Transfer to Level 1 measurement - Public Warrants (10,212,500) Change in fair value of derivative warrant liabilities 630,000 Level 3 Derivative warrant liabilities at December 31, 2020 $ 6,615,000

Quarterly Financial Information

Quarterly Financial Information (Unaudited)	6 Months Ended
	Dec. 31, 2020
Quarterly Financial Information (Unaudited)
Quarterly Financial Information (Unaudited)	Note 10—Quarterly Financial Information (Unaudited) The following tables contain unaudited consolidated quarterly financial information for the quarterly period ended September 30, 2020 that has been updated to reflect the restatement and revision of the Company’s consolidated financial statements as described in Note 2—Restatement of Previously Issued Financial Statements. The restatement and revision had no impact on net cash flows from operating, investing or financing activities. The Company has not amended its previously filed Quarterly Report on Form 10-Q for the Affected Period. The financial information that has been previously filed or otherwise reported for the Affected Period is superseded by the information in this Annual Report, and the financial statements and related financial information for the Affected Period contained in such previously filed report should no longer be relied upon. As of September 30, 2020 As Previously Restatement Reported Adjustment As Restated Balance Sheet Total assets $ 216,445,723 $ — $ 216,445,723 Liabilities and shareholders’ equity Total current liabilities $ 161,956 $ — $ 161,956 Deferred legal fees — Deferred underwriting commissions 7,525,000 — 7,525,000 Derivative warrant liabilities — 16,197,500 16,197,500 Total liabilities 7,686,956 16,197,500 23,884,456 Class A ordinary shares, $0.0001 par value; shares subject to possible redemption 203,758,760 (16,197,500) 187,561,260 Shareholders’ equity Preference shares - $0.0001 par value — — — Class A ordinary shares - $0.0001 par value 112 162 274 Class B ordinary shares - $0.0001 par value 538 — 538 Additional paid-in-capital 5,190,381 601,798 5,792,179 Accumulated deficit (191,024) (601,960) (792,984) Total shareholders’ equity 5,000,007 — 5,000,007 Total liabilities and shareholders’ equity $ 216,445,723 $ — $ 216,445,723 Period From June 24, 2020 (Inception) Through September 30, 2020 As Previously Restatement Reported Adjustment As Restated Unaudited Condensed Statement of Operations Loss from operations $ (201,002) $ — $ (201,002) Other (expense) income: Change in fair value of warrant liabilities — — — Offering costs associated with derivative warrant liabilities — (601,960) (601,960) Net gain from investments held in Trust Account 9,978 — 9,978 Total other (expense) income 9,978 (601,960) (591,982) Net loss $ (191,024) $ (601,960) $ (792,984) Basic and Diluted weighted-average Class A ordinary shares outstanding 21,500,000 — 21,500,000 Basic and Diluted net loss per Class A share $ — $ Basic and Diluted weighted-average Class B ordinary shares outstanding 5,162,280 — 5,162,280 Basic and Diluted net loss per Class B share $ (0.04) — $ (0.16) Period From June 24, 2020 (Inception) Through September 30, 2020 As Previously Restatement Reported Adjustment As Restated Unaudited Condensed Statement of Cash Flows Net loss $ (191,024) $ (601,960) $ (792,984) Offering costs associated with derivative warrant liabilities — 601,960 601,960 Net cash used in operating activities (393,915) — (393,915) Net cash used in investing activities (215,000,000) — (215,000,000) Net cash provided by financing activities 216,459,791 — 216,459,791 Net change in cash $ 1,065,876 $ — $ 1,065,876

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	6 Months Ended
	Dec. 31, 2020
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS	NOTE 11. SUBSEQUENT EVENTS The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Based upon this review other than as described in footnote 2, and the items below, the Company did not identify any subsequent events that would have required adjustment or disclosure in the consolidated financial statements. On February 23, 2021, the Company entered into Merger Agreement, by and among the Company, Caspian Merger Sub Inc., a Delaware corporation and direct, wholly owned subsidiary of the Company formed on February 22, 2021 (“Merger Sub”), and MarkForged, Inc. (“Markforged”). The Merger Agreement and the transactions contemplated thereby were approved by the boards of directors of each of the Company and Markforged. In connection with the Merger Agreement, upon the terms and subject to the conditions of the Merger Agreement, the following transactions, among other things, are expected to occur: (i) prior to the effective time of the transactions contemplated by the Merger Agreement (the “ Effective Time ”), the Company will domesticate as a Delaware corporation in accordance with Section 388 of the Delaware General Corporation Law, as amended (the “ DGCL ”), and the Cayman Islands Companies Law (As Revised) (the “ Domestication ”); (ii) prior to the Effective Time, all issued and outstanding shares of preferred stock of Markforged will convert into shares of common stock of Markforged; (iii) prior to the Effective Time, Markforged will repurchase up to approximately $45 million of Markforged securities held by certain of its shareholders (the “ Employee Transactions ”); (iv) at the Effective Time, upon the terms and subject to the conditions of the Merger Agreement and in accordance with the DGCL, Merger Sub will merge with and into Markforged, with Markforged continuing as the surviving corporation and a wholly owned subsidiary of the Company (the “ Merger ”); (v) at the Effective Time, and after the Domestication, each issued and outstanding share of common stock of Markforged, excluding the shares repurchased in the Employee Transactions, will be cancelled and converted into the right to receive a number of shares of common stock of the Company, par value $0.0001 per share (the “ Company Common Stock ”), equal to the product of (x) one share of Markforged common stock and (y) the Exchange Ratio (as defined below) (such aggregate number of shares of Company Common Stock, the “ Aggregate Merger Consideration ”); and (iv) upon the consummation of the Merger (the “ Closing ”), the Company will be renamed “Markforged Holding Corporation.” In connection with the Domestication, (i) each then issued and outstanding Class A ordinary share of the Company, par value $0.0001 per share (the “Class A Ordinary Shares”), and each then issued and outstanding Class B ordinary share of the Company, par value $0.0001 per share (the “Class B Ordinary Shares”), will convert into one share of Company Common Stock, (ii) each then issued and outstanding warrant of the Company will convert automatically into a warrant to acquire one share of Company Common Stock, pursuant to the Company’s existing warrant agreement, and (iii) each then issued and outstanding unit of the Company that has not previously been separated into its underlying securities will be cancelled and the holder thereof will receive one share of Company Common Stock and one-fourth of one warrant to purchase Company Common Stock. The Exchange Ratio is defined as (i) $1,700,000,000 minus the total dollar amount paid by the Company in connection with the Employee Transactions, divided by (ii) $10.00, divided by (iii) the number of issued and outstanding shares of Markforged common stock, on a fully diluted and as-converted basis (including shares subject to outstanding equity awards of Markforged (“Markforged Equity Awards”) and shares available for issuance in respect of Markforged Equity Awards not yet granted under the Markforged equity incentive plan). In addition, the outstanding Markforged Equity Awards will be converted into equity awards of the Company, on the terms provided in the Merger Agreement. The holders of Markforged common stock and Markforged Equity Awards (whether vested or not) immediately prior to the Effective Time will be entitled to receive, on a pro rata basis, up to 14,666,667 additional shares of Company Common Stock (“Earnout Shares”) as follows: (i) if the volume-weighted average price of Company Common Stock is at least $12.50 for any 20 days in a consecutive 30‑trading day period, 8,000,000 Earnout Shares will be issued, (ii) if the volume-weighted average price of Company Common Stock is at least $15.00 for any 20 days in a consecutive 30‑trading day period, 6,666,667 Earnout Shares will be issued and (iii) upon a change of control or a liquidation of the Company, all previously unearned Earnout Shares will be issued. Markforged shareholders will not receive any Earnout Shares not earned within five years of the Closing. The Merger Agreement is subject to the satisfaction or waiver of certain customary closing conditions and additional closing conditions, including, among others: (i) approval of the Merger and related agreements and transactions by the shareholders of the Company and by the shareholders of Markforged, (ii) the effectiveness of the merger proxy statement / registration statement on Form S‑4 to be filed by the Company in connection with the Merger, (iii) expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (the “HSR Act”), (iv) receipt of approval for listing on The New York Stock Exchange (the “NYSE”) for the shares of Company Common Stock to be issued in connection with the Merger, (v) the Company having at least $5,000,001 of net tangible assets upon Closing and (vi) the size and composition of the board of directors of the Company after giving effect to the Merger being composed as agreed upon by the parties. The Merger Agreement may be terminated under certain customary circumstances prior to the Closing. Certain Related Agreements Also, in connection with Merger Agreement, the Company entered into certain related agreements including Subscription Agreements, Sponsor Support Agreement, Shareholder Support Agreement. For more information, the Company’s announcement and the related agreements have been filed on a Current Report on Form 8‑K on February 24, 2021. The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date the financial statements were available to be issued. Other than what is discussed herein, the Company did not identify any other subsequent events that would have required adjustment or disclosure in the financial statements.

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	6 Months Ended
	Dec. 31, 2020
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of presentation	Basis of presentation The accompanying financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for financial information and pursuant to the rules and regulations of the SEC. As described in Note 2—Restatement of Previously Issued Financial Statements and Note 10 – Quarterly Financial Information (unaudited), the Company’s financial statements for the period from June 24, 2020 (inception) through December 31, 2020, and for the unaudited interim periods ended September 30, 2020 (collectively, the “Affected Periods”), are restated in this Annual Report on Form 10-K/A (Amendment No. 1) (this “Annual Report”) to correct the misapplication of accounting guidance related to the Company’s warrants in the Company’s previously issued audited and unaudited condensed financial statements for such periods. The restated financial statements are indicated as “Restated” in the audited and unaudited condensed financial statements and accompanying notes, as applicable. See Note 2—Restatement of Previously Issued Financial Statements for further discussion.
Emerging growth company	Emerging growth company As an emerging growth company, the Company may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statement with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Concentration of credit risk	Concentration of credit risk Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal depository insurance coverage of $250,000, and investments held in Trust Account. At December 31, 2020, the Company had not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.
Investments Held in the Trust Account	Investments Held in the Trust Account The Company’s portfolio of investments held in the Trust Account is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities, or a combination thereof. The Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in net gain from investments held in Trust Account in the accompanying statement of operations. The estimated fair values of investments held in the Trust Account are determined using available market information.
Fair Value of Financial Instruments	Fair Value of Financial Instruments Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. U.S. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: · Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; · Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and · Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. As of December 31, 2020, the carrying values of cash, prepaid expenses, accounts payable and accrued expenses, which qualify as financial instruments under the FASB ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the balance sheet. The Company’s investments held in Trust Account are comprised of investments in U.S. Treasury securities with an original maturity of 185 days or less or investments in a money market funds that comprise only U.S. Treasury securities and are recognized at fair value. The fair value of investments held in Trust Account is determined using quoted prices in active markets.
Use of estimates	Use of estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. There were no cash equivalents at December 31, 2020.
Offering costs associated with Initial Public Offering	Offering costs associated with Initial Public Offering The Company complied with the requirements of the ASC 340-10-S99-1. Offering costs consist legal, accounting, underwriting fees and other incremental costs directly attributable to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with warrant liabilities are expensed as incurred, presented as non-operating expenses in the statement of operations. Offering costs associated with the Public Shares were charged to shareholders’ equity upon the completion of the Initial Public Offering.
Derivative Warrant liabilities	Derivative Warrant liabilities The Company does not use derivative instruments to hedge its exposures to cash flow, market, or foreign currency risks. Management evaluates all of the Company’s financial instruments, including issued warrants to purchase its Class A ordinary shares, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and ASC 815-15. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. The Company issued 5,375,000 warrants to purchase Class A ordinary shares to investors in the Company’s Initial Public Offering and simultaneously issued 3,150,000 Private Placement Warrants. All of the Company’s outstanding warrants are recognized as derivative liabilities in accordance with ASC 815-40. Accordingly, we recognize the warrant instruments as liabilities at fair value and adjust the instruments to fair value at each reporting period. The liabilities are subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in our statement of operations. The fair value of the Public Warrants issued in connection with the Public Offering and Private Placement Warrants were initially measured at fair value using a Binomial Lattice in a risk-neutral framework. For each modeled future price, the warrant payoff is calculated based on the contractual terms (incorporating any optimal early exercise / redemption), and then discounted at the term-matched risk-free rate. Finally, the value of the warrants is calculated as the probability-weighted present value over all future modeled payoffs. The fair value of Public Warrants subsequently been measured based on the listed market price of such warrants while the fair value of the Private Placement Warrants continue to be estimated using a Binomial Lattice model.
Class A Ordinary Shares subject to possible redemption	Class A Ordinary Shares subject to possible redemption The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Shares of Class A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Shares of conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, shares of Class A ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, at December 31, 2020, 18,574,269 shares of Class A ordinary shares subject to possible redemption are presented as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheets.
Net income (loss) per ordinary share	Net income (loss) per ordinary share The Company complies with accounting and disclosure requirements of ASC Topic 260, “Earnings Per Share.” Net loss per share is computed by dividing net loss by the weighted average number of ordinary shares outstanding during the period. The Company has not considered the effect of the warrants sold in the Initial Public Offering and Private Placement to purchase an aggregate of 8,525,000 shares of Class A ordinary shares in the calculation of diluted earnings per share, since their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted loss per ordinary share is the same as basic loss per ordinary share for the periods presented. The Company’s statement of operations includes a presentation of income per share for ordinary share subject to redemption in a manner similar to the two-class method of income per share. Net income per share, basic and diluted for Class A ordinary shares is calculated by dividing the investment income earned on the Trust Account of approximately $76,000 for the period from June 24, 2020 (inception) to December 31, 2020, by the weighted average number of shares of Class A ordinary shares outstanding for the period. Net loss per share, basic and diluted for Class B ordinary shares is calculated by dividing the net loss of approximately $2.6 million, less income attributable to Class A ordinary shares, by the weighted average number of shares of Class B ordinary shares outstanding for the period.
Income taxes	Income taxes ASC Topic 740, “Income Taxes” prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts for interest and penalties as of December 31, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman federal income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.
Recent Accounting Pronouncements	Recent accounting pronouncements Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements.

RESTATEMENT OF PREVIOUSLY ISS_2

RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Tables)	6 Months Ended
	Dec. 31, 2020
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS
Schedule of impact of the restatement on the Consolidated Balance Sheet, Consolidated Statement of Operations and Consolidated Statement of Cash Flows	The impact of the restatement on the balance sheets, statements of operations and statements of cash flows for the Affected Periods is presented below. The restatement had no impact on net cash flows from operating, investing or financing activities. As of December 31, 2020 As Previously Restatement Reported Adjustment As Restated Balance Sheet Total assets $ 216,310,399 $ — $ 216,310,399 Liabilities and shareholders’ equity Total current liabilities $ 140,207 $ — $ 140,207 Deferred legal fees — — Deferred underwriting commissions 7,525,000 — 7,525,000 Derivative warrant liabilities — 17,902,500 17,902,500 Total liabilities 7,665,207 17,902,500 25,567,707 Class A ordinary shares, $0.0001 par value; shares subject to possible redemption 203,645,190 (17,902,500) 185,742,690 Shareholders’ equity Preference shares - $0.0001 par value — — — Class A ordinary shares - $0.0001 par value 114 179 293 Class B ordinary shares - $0.0001 par value 538 — 538 Additional paid-in-capital 5,303,949 2,306,781 7,610,730 Accumulated deficit (304,599) (2,306,960) (2,611,559) Total shareholders’ equity 5,000,002 — 5,000,002 Total liabilities and shareholders’ equity $ 216,310,399 $ — $ 216,310,399 Period From June 24, 2020 (Inception) Through December 31, 2020 As Previously Restatement Reported Adjustment As Restated Statement of Operations Loss from operations $ (380,824) $ — $ (380,824) Other (expense) income: Change in fair value of derivative warrant liabilities — (1,705,000) (1,705,000) Offering costs associated with derivative warrant liabilities — (601,960) (601,960) Net gain from investments held in Trust Account 76,225 — 76,225 Total other (expense) income 76,225 (2,306,960) (2,230,735) Net loss $ (304,599) $ (2,306,960) $ (2,611,559) Basic and Diluted weighted-average Class A ordinary shares outstanding 21,500,000 — 21,500,000 Basic and Diluted net loss per Class A share $ — $ Basic and Diluted weighted-average Class B ordinary shares outstanding 5,265,873 — 5,265,873 Basic and Diluted net loss per Class B share $ (0.07) — $ (0.51) Period From June 24, 2020 (Inception) Through December 31, 2020 As Previously Restatement Reported Adjustment As Restated Statement of Cash Flows Net loss $ (304,599) $ (2,306,960) $ (2,611,559) Change in fair value of derivative warrant liabilities — 1,705,000 1,705,000 Offering costs associated with derivative warrant liabilities — 601,960 601,960 Net cash used in operating activities (614,968) — (614,968) Net cash used in investing activities (215,000,000) — (215,000,000) Net cash provided by financing activities 216,534,791 — 216,534,791 Net change in cash $ 919,823 $ — $ 919,823 There is no change to total shareholders’ equity at the reported balance sheet date. As of September 30, 2020 As Previously Restatement Reported Adjustment As Restated Balance Sheet Total assets $ 216,445,723 $ — $ 216,445,723 Liabilities and shareholders’ equity Total current liabilities $ 161,956 $ — $ 161,956 Deferred legal fees — Deferred underwriting commissions 7,525,000 — 7,525,000 Derivative warrant liabilities — 16,197,500 16,197,500 Total liabilities 7,686,956 16,197,500 23,884,456 Class A ordinary shares, $0.0001 par value; shares subject to possible redemption 203,758,760 (16,197,500) 187,561,260 Shareholders’ equity Preference shares - $0.0001 par value — — — Class A ordinary shares - $0.0001 par value 112 162 274 Class B ordinary shares - $0.0001 par value 538 — 538 Additional paid-in-capital 5,190,381 601,798 5,792,179 Accumulated deficit (191,024) (601,960) (792,984) Total shareholders’ equity 5,000,007 — 5,000,007 Total liabilities and shareholders’ equity $ 216,445,723 $ — $ 216,445,723

FAIR VALUE MEASUREMENTS (Tables

FAIR VALUE MEASUREMENTS (Tables)	6 Months Ended
	Dec. 31, 2020
FAIR VALUE MEASUREMENTS
Summary of financial assets that are measured at fair value on a recurring basis	Quoted Prices in Significant Other Significant Other Active Markets Observable Inputs Unobservable Inputs Description (Level 1) (Level 2) (Level 3) Assets: Investments held in Trust Account $ 215,076,225 $ — $ — Liabilities: Derivative warrant liabilities - Public $ 11,287,500 $ — $ — Derivative warrant liabilities - Private $ — $ — $ 6,615,000
Schedule of financial liabilities subject to fair value measurements on a recurring basis	As of August 20, 2020 As of December 31, 2020 Volatility 45.0 % 25.8 % Stock price n/a $10.77 Risk-free rate 0.35 % 0.43 % Dividend yield % %
Schedule of change in Level 3 fair value measurements	The change in the fair value of Level 3 fair value measurements for the period from June 24, 2020 (inception) through December 31, 2020 is summarized as follows: Level 3 Derivative warrant liabilities at June 24, 2020 (inception) $ — Issuance of Public and Private Warrants 16,197,500 Transfer to Level 1 measurement - Public Warrants (10,212,500) Change in fair value of derivative warrant liabilities 630,000 Level 3 Derivative warrant liabilities at December 31, 2020 $ 6,615,000

Quarterly Financial Informati_2

Quarterly Financial Information (Unaudited) (Tables)	6 Months Ended
	Dec. 31, 2020
Quarterly Financial Information (Unaudited)
Schedule of quarterly financial information	As of September 30, 2020 As Previously Restatement Reported Adjustment As Restated Balance Sheet Total assets $ 216,445,723 $ — $ 216,445,723 Liabilities and shareholders’ equity Total current liabilities $ 161,956 $ — $ 161,956 Deferred legal fees — Deferred underwriting commissions 7,525,000 — 7,525,000 Derivative warrant liabilities — 16,197,500 16,197,500 Total liabilities 7,686,956 16,197,500 23,884,456 Class A ordinary shares, $0.0001 par value; shares subject to possible redemption 203,758,760 (16,197,500) 187,561,260 Shareholders’ equity Preference shares - $0.0001 par value — — — Class A ordinary shares - $0.0001 par value 112 162 274 Class B ordinary shares - $0.0001 par value 538 — 538 Additional paid-in-capital 5,190,381 601,798 5,792,179 Accumulated deficit (191,024) (601,960) (792,984) Total shareholders’ equity 5,000,007 — 5,000,007 Total liabilities and shareholders’ equity $ 216,445,723 $ — $ 216,445,723 Period From June 24, 2020 (Inception) Through September 30, 2020 As Previously Restatement Reported Adjustment As Restated Unaudited Condensed Statement of Operations Loss from operations $ (201,002) $ — $ (201,002) Other (expense) income: Change in fair value of warrant liabilities — — — Offering costs associated with derivative warrant liabilities — (601,960) (601,960) Net gain from investments held in Trust Account 9,978 — 9,978 Total other (expense) income 9,978 (601,960) (591,982) Net loss $ (191,024) $ (601,960) $ (792,984) Basic and Diluted weighted-average Class A ordinary shares outstanding 21,500,000 — 21,500,000 Basic and Diluted net loss per Class A share $ — $ Basic and Diluted weighted-average Class B ordinary shares outstanding 5,162,280 — 5,162,280 Basic and Diluted net loss per Class B share $ (0.04) — $ (0.16) Period From June 24, 2020 (Inception) Through September 30, 2020 As Previously Restatement Reported Adjustment As Restated Unaudited Condensed Statement of Cash Flows Net loss $ (191,024) $ (601,960) $ (792,984) Offering costs associated with derivative warrant liabilities — 601,960 601,960 Net cash used in operating activities (393,915) — (393,915) Net cash used in investing activities (215,000,000) — (215,000,000) Net cash provided by financing activities 216,459,791 — 216,459,791 Net change in cash $ 1,065,876 $ — $ 1,065,876

DESCRIPTION OF ORGANIZATION, _2

DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS (Details) - USD ($)	Aug. 20, 2020	Jun. 26, 2020	Dec. 31, 2020	Sep. 30, 2020
Proposed Public Offering
Offering costs paid			$ 4,667,355
Deferred underwriting commissions	$ 7,500,000		7,525,000	$ 7,525,000
Cash held in operating bank account			900,000
Working capital			1,100,000
Issuance of ordinary shares to Sponsor			25,000
Aggregate purchase price			25,000
Proceeds from related party loan			65,000
Sponsor
Proposed Public Offering
Shares issued, price per share		$ 0.004
Fair value of stock issued			25,000
Related party notes, outstanding balance			$ 0
Issuance of ordinary shares to Sponsor		$ 5,750,000
Aggregate purchase price		5,750,000
Sponsor | Sponsor Loan
Proposed Public Offering
Proceeds from related party loan		$ 163,000
Class A ordinary shares
Proposed Public Offering
Common stock, par value			$ 0.0001
Initial Public Offering
Proposed Public Offering
Number of shares issued	21,500,000		1,500,000
Shares issued, price per share	$ 10
Gross proceeds	$ 215,000,000
Offering costs paid	12,400,000
Deferred underwriting commissions	$ 7,500,000
Number of warrants issued			5,375,000
Shares issuable per warrant	1
Issuance of ordinary shares to Sponsor	$ 215,000,000
Threshold tangible assets	$ 5,000,001
Maximum percentage of shares that can be redeemed without prior consent of the Company	15.00%
Threshold, ownership	100.00%
Threshold, (in days, months)	24 days
Windown (in days)	10 days
Maximum amount of interest to pay dissolution expenses	$ 100,000
Aggregate purchase price	$ 215,000,000
Private Placement
Proposed Public Offering
Number of shares issued	3,150,000
Shares issued, price per share	$ 2
Gross proceeds	$ 12,400,000
Offering costs paid	6,300,000
Deferred underwriting commissions	$ 7,500,000
Number of warrants issued	3,150,000		3,150,000
Price of warrants (in dollars per share)	$ 2
Proceeds from issuance of warrants	$ 6,300,000
Shares issuable per warrant	1
Exercise price of warrants	$ 11.50
Threshold, Market value assets (as a percent)	80.00%
Threshold, ownership	50.00%
Threshold, (in days, months)	30 days
Over-allotment
Proposed Public Offering
Number of shares issued	1,500,000

RESTATEMENT OF PREVIOUSLY ISS_3

RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS - Balance Sheets (Details) - USD ($)	Dec. 31, 2020	Sep. 30, 2020	Aug. 20, 2020	Jun. 23, 2020
BALANCE SHEET
Total assets	$ 216,310,399	$ 216,445,723
Liabilities and Shareholder's Equity
Total current liabilities	140,207	161,956
Deferred legal fees	0	0
Deferred underwriting commissions	7,525,000	7,525,000	$ 7,500,000
Derivative warrant liabilities	17,902,500	16,197,500
Total liabilities	25,567,707	23,884,456
Class A ordinary shares, $0.0001 par value; shares subject to possible redemption	185,742,690
Shareholder's Equity:
Preference shares - $0.0001 par value	0	0
Additional paid-in capital	7,610,730	5,792,179
Accumulated deficit	(2,611,559)	(792,984)
Total shareholders' equity	5,000,002	5,000,007		$ 0
Total Liabilities and Shareholders' Equity	$ 216,310,399	216,445,723
Class A ordinary shares, par value	$ 0.0001
Preferred stock, par value	$ 0.0001
Class A ordinary shares
Liabilities and Shareholder's Equity
Class A ordinary shares, $0.0001 par value; shares subject to possible redemption		187,561,260
Shareholder's Equity:
Common stock	$ 293	274
Common shares, par value (in dollars per share)	$ 0.0001
Class B ordinary shares
Shareholder's Equity:
Common stock	$ 538	538
Common shares, par value (in dollars per share)	$ 0.0001
As Previously Reported
BALANCE SHEET
Total assets	$ 216,310,399	216,445,723
Liabilities and Shareholder's Equity
Total current liabilities	140,207	161,956
Deferred legal fees	0	0
Deferred underwriting commissions	7,525,000	7,525,000
Derivative warrant liabilities	0	0
Total liabilities	7,665,207	7,686,956
Class A ordinary shares, $0.0001 par value; shares subject to possible redemption	203,645,190
Shareholder's Equity:
Preference shares - $0.0001 par value	0	0
Additional paid-in capital	5,303,949	5,190,381
Accumulated deficit	(304,599)	(191,024)
Total shareholders' equity	5,000,002	5,000,007
Total Liabilities and Shareholders' Equity	$ 216,310,399	$ 216,445,723
Preferred stock, par value	$ 0.0001	$ 0.0001
As Previously Reported | Class A ordinary shares
Liabilities and Shareholder's Equity
Class A ordinary shares, $0.0001 par value; shares subject to possible redemption		$ 203,758,760
Shareholder's Equity:
Common stock	$ 114	$ 112
Class A ordinary shares, par value	$ 0.0001	$ 0.0001
Common shares, par value (in dollars per share)	$ 0.0001	$ 0.0001
As Previously Reported | Class B ordinary shares
Shareholder's Equity:
Common stock	$ 538	$ 538
Common shares, par value (in dollars per share)	$ 0.0001	$ 0.0001
Restatement Adjustment
BALANCE SHEET
Total assets	$ 0	$ 0
Liabilities and Shareholder's Equity
Total current liabilities	0	0
Deferred legal fees	0	0
Deferred underwriting commissions	0	0
Derivative warrant liabilities	17,902,500	16,197,500
Total liabilities	17,902,500	16,197,500
Class A ordinary shares, $0.0001 par value; shares subject to possible redemption	(17,902,500)
Shareholder's Equity:
Preference shares - $0.0001 par value	0	0
Additional paid-in capital	2,306,781	601,798
Accumulated deficit	(2,306,960)	(601,960)
Total shareholders' equity	0	0
Total Liabilities and Shareholders' Equity	0	0
Restatement Adjustment | Class A ordinary shares
Liabilities and Shareholder's Equity
Class A ordinary shares, $0.0001 par value; shares subject to possible redemption		(16,197,500)
Shareholder's Equity:
Common stock	179	162
Restatement Adjustment | Class B ordinary shares
Shareholder's Equity:
Common stock	$ 0	$ 0

RESTATEMENT OF PREVIOUSLY ISS_4

RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS - Statements of operations (Details) - USD ($)	3 Months Ended	6 Months Ended
	Sep. 30, 2020	Dec. 31, 2020
STATEMENT OF OPERATIONS
Loss from operations	$ (201,002)	$ (380,824)
Other (expense) income:
Change in fair value of derivative warrant liabilities		(1,705,000)
Offering costs associated with derivative warrant liabilities	(601,960)	(601,960)
Net gain from investments held in Trust Account	9,978	76,225
Total other (expense) income	(591,982)	(2,230,735)
Net loss	$ (792,984)	$ (2,611,559)
Class A ordinary shares
Other (expense) income:
Basic and diluted weighted average shares outstanding	21,500,000	21,500,000
Basic and diluted net loss per share	$ 0	$ 0
Class B ordinary shares
Other (expense) income:
Basic and diluted weighted average shares outstanding	5,162,280	5,265,873
Basic and diluted net loss per share	$ (0.16)	$ (0.51)
As Previously Reported
STATEMENT OF OPERATIONS
Loss from operations	$ (201,002)	$ (380,824)
Other (expense) income:
Change in fair value of derivative warrant liabilities		0
Offering costs associated with derivative warrant liabilities		0
Net gain from investments held in Trust Account	9,978	76,225
Total other (expense) income	9,978	76,225
Net loss	$ (191,024)	$ (304,599)
As Previously Reported | Class A ordinary shares
Other (expense) income:
Basic and diluted weighted average shares outstanding	21,500,000	21,500,000
Basic and diluted net loss per share	$ 0	$ 0
As Previously Reported | Class B ordinary shares
Other (expense) income:
Basic and diluted weighted average shares outstanding	5,162,280	5,265,873
Basic and diluted net loss per share	$ (0.04)	$ (0.07)
Restatement Adjustment
STATEMENT OF OPERATIONS
Loss from operations		$ 0
Other (expense) income:
Change in fair value of derivative warrant liabilities		(1,705,000)
Offering costs associated with derivative warrant liabilities	$ (601,960)	(601,960)
Net gain from investments held in Trust Account		0
Total other (expense) income	(601,960)	(2,306,960)
Net loss	$ (601,960)	$ (2,306,960)
Restatement Adjustment | Class A ordinary shares
Other (expense) income:
Basic and diluted weighted average shares outstanding		0
Basic and diluted net loss per share		$ 0
Restatement Adjustment | Class B ordinary shares
Other (expense) income:
Basic and diluted weighted average shares outstanding		0
Basic and diluted net loss per share		$ 0

RESTATEMENT OF PREVIOUSLY ISS_5

RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS - Statements of cash flows (Details) - USD ($)	3 Months Ended	6 Months Ended
	Sep. 30, 2020	Dec. 31, 2020
STATEMENT OF CASH FLOWS
Net loss	$ (792,984)	$ (2,611,559)
Change in fair value of derivative warrant liabilities		1,705,000
Offering costs associated with derivative warrant liabilities	601,960	601,960
Net cash used in operating activities	(393,915)	(614,968)
Net cash used in investing activities	(215,000,000)	(215,000,000)
Net cash provided by financing activities	216,459,791	216,534,791
Net change in cash	1,065,876	919,823
As Previously Reported
STATEMENT OF CASH FLOWS
Net loss	(191,024)	(304,599)
Change in fair value of derivative warrant liabilities		0
Offering costs associated with derivative warrant liabilities		0
Net cash used in operating activities	(393,915)	(614,968)
Net cash used in investing activities	(215,000,000)	(215,000,000)
Net cash provided by financing activities	216,459,791	216,534,791
Net change in cash	1,065,876	919,823
Restatement Adjustment
STATEMENT OF CASH FLOWS
Net loss	(601,960)	(2,306,960)
Change in fair value of derivative warrant liabilities		1,705,000
Offering costs associated with derivative warrant liabilities	601,960	601,960
Net cash used in operating activities	0	0
Net cash used in investing activities	0	0
Net cash provided by financing activities	0	0
Net change in cash	$ 0	$ 0

RESTATEMENT OF PREVIOUSLY ISS_6

RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS - Additional Information (Details) - USD ($)	1 Months Ended	6 Months Ended
	Aug. 31, 2020	Dec. 31, 2020
Class of Warrant or Right [Line Items]
Change in fair value of derivative warrant liabilities		$ 1,705,000
Public And Private Warrants
Class of Warrant or Right [Line Items]
Change in fair value of derivative warrant liabilities	$ 16,200,000

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)	3 Months Ended	6 Months Ended
	Sep. 30, 2020	Dec. 31, 2020	Aug. 20, 2020
Class A ordinary shares, shares subject to possible redemption		18,574,269
Antidilutive securities excluded from computation		8,525,000
Investment income earned on the Trust Account	$ 9,978	$ 76,225
Unrecognized tax benefits		0
Unrecognized tax benefits accrued for interest and penalties		0
Federal depository insurance coverage		250,000
Net loss	$ (792,984)	$ (2,611,559)
Private Placement
Number of warrants issued		3,150,000	3,150,000
Initial Public Offering
Number of warrants issued		5,375,000

INITIAL PUBLIC OFFERING (Detail

INITIAL PUBLIC OFFERING (Details) - USD ($)	Aug. 20, 2020	Dec. 31, 2020	Sep. 30, 2020
Proposed Public Offering
Offering costs paid		$ 4,667,355
Net Proceeds	$ 215,000,000
Deferred underwriting commissions	$ 7,500,000	$ 7,525,000	$ 7,525,000
Initial Public Offering
Proposed Public Offering
Number of shares issued	21,500,000	1,500,000
Share Price	$ 10
Offering costs paid	$ 12,400,000
Gross proceeds	215,000,000
Deferred underwriting commissions	$ 7,500,000
Number of shares in a unit	1
Number of warrants in a unit	1
Number of shares called by each warrant	1
Over-allotment
Proposed Public Offering
Number of shares issued	1,500,000
Private Placement
Proposed Public Offering
Number of shares issued	3,150,000
Share Price	$ 2
Offering costs paid	$ 6,300,000
Gross proceeds	12,400,000
Deferred underwriting commissions	$ 7,500,000
Number of shares called by each warrant	1
Exercise price of warrants	$ 11.50

RELATED PARTY TRANSACTIONS - Fo

RELATED PARTY TRANSACTIONS - Founder Shares (Details)	Aug. 20, 2020USD ($)shares	Aug. 10, 2020shares	Jun. 26, 2020USD ($)$ / sharesshares	Dec. 31, 2020USD ($)$ / shares
Related Party Transactions
Issuance of ordinary shares to Sponsor				$ 25,000
Threshold outstanding shares (as percent)			20.00%
Proceeds from related party loan				$ 65,000
Class B ordinary shares
Related Party Transactions
Common stock, par value | $ / shares				$ 0.0001
Subject to forfeiture (in shares) | shares	750,000		750,000
Threshold outstanding shares (as percent)	20.00%
Sponsor Loan | Class B ordinary shares
Related Party Transactions
Forfeiture of founder shares (in shares) | shares	375,000
Sponsor
Related Party Transactions
Issuance of ordinary shares to Sponsor			$ 5,750,000
Share Price | $ / shares			$ 0.004
Threshold stock price | $ / shares			$ 12
Threshold trading days			20
Threshold trading period			30
Threshold commencement			150 days
Sponsor | Five Individuals
Related Party Transactions
Number of shares transferred (in shares) | shares		25,000
Sponsor | One individual
Related Party Transactions
Number of shares transferred (in shares) | shares		30,000
Sponsor | Class B ordinary shares
Related Party Transactions
Common stock, par value | $ / shares			$ 0.0001
Offering costs paid by Sponsor			$ 25,000
Forfeiture of founder shares (in shares) | shares	375,000
Forfeiture of founder shares	$ 0
Sponsor | Sponsor Loan
Related Party Transactions
Proceeds from related party loan			$ 163,000

RELATED PARTY TRANSACTIONS - Pr

RELATED PARTY TRANSACTIONS - Private Placement Warrants (Details) - Private Placement - USD ($) $ / shares in Units, $ in Millions	Aug. 20, 2020	Dec. 31, 2020
Related Party Transactions
Number of warrants issued	3,150,000	3,150,000
Price of warrants (in dollars per share)	$ 2
Issuance of Public and Private Warrants	$ 6.3
Shares issuable per warrant	1
Exercise price of warrants	$ 11.50
Threshold, (in days, months)	30 days

RELATED PARTY TRANSACTIONS - Wo

RELATED PARTY TRANSACTIONS - Working Capital and Support (Details) - USD ($)	Jun. 26, 2020	Dec. 31, 2020	Aug. 20, 2020
Related Party Transactions
Proceeds from related party loan		$ 65,000
Administrative support agreement, per month		10,000
Administrative expenses - related party		40,000
Private Placement
Related Party Transactions
Price of warrants (in dollars per share)			$ 2
Sponsor
Related Party Transactions
Conversion of debt	$ 1,500,000
Related party notes, outstanding balance		0
Administrative expenses - related party		$ 40,000
Sponsor | Sponsor Loan
Related Party Transactions
Maximum borrowing capacity	300,000
Proceeds from related party loan	$ 163,000

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Details) - USD ($)	Aug. 20, 2020	Dec. 31, 2020
Maximum number of demands for registration of securities		three demands
Deferred underwriting fee payable		$ 7,500,000
Sponsor | Class B ordinary shares
Forfeiture of founder shares (in shares)	375,000
Forfeiture of founder shares	$ 0
Over-allotment
Number of shares issued	1,500,000
Underwriting discount per unit		$ 0.20
Cash underwriting fees		$ 4,300,000
Deferred fee per unit		$ 0.35
Over-allotment | Class B ordinary shares
Number of shares issued	1,500,000
Initial Public Offering
Number of shares issued	21,500,000	1,500,000
Underwriting agreement options granted period		45 days

DERIVATIVE WARRANT LIABILITIES

DERIVATIVE WARRANT LIABILITIES (Details) - $ / shares	Aug. 20, 2020	Dec. 31, 2020
Private Placement
Warrants
Exercise price of warrants	$ 11.50
Threshold, (in days, months)	30 days
Initial Public Offering
Warrants
Threshold, (in days, months)	24 days
Warrant
Warrants
Exercise price of warrants		$ 11.50
Public warrants expiration term		5 years
Share price		$ 9.20
Threshold minimum percentage of gross proceeds on total equity proceeds (as a percent)		50.00%
Adjustment of exercise price of warrants based on market value and newly issued price (as a percent)		115.00%
Stock price trigger for redemption of public warrants (in dollars per share)		$ 18
Adjustment two of redemption price of stock based on market value and newly issued price (as a percent)		180.00%
Threshold period for not to transfer, assign or sell any of their shares or warrants after the completion of the initial business combination		30 days
Threshold trading days for redemption of public warrants		20 days
Warrant | Redemption Of Warrants When Price Per Share Of Class Common Stock Equals Or Exceeds18.00
Warrants
Stock price trigger for redemption of public warrants (in dollars per share)		$ 18
Threshold trading days for redemption of public warrants		20 days
Redemption price per warrant (in dollars per share)		$ 0.01
Threshold trading days for calculating Market Value		30 days
Warrant | Redemption of Warrants, Commencing Ninety Days after Warrants Become Exercisable
Warrants
Minimum threshold written notice period for redemption of public warrants		30 days
Stock price trigger for redemption of public warrants (in dollars per share)		$ 0.10
Warrant | Redemption Of Warrants When Price Per Share Of Class Common Stock Equals Or Exceeds10.00
Warrants
Share price		$ 10
Warrant | Class A ordinary shares
Warrants
Threshold trading days for calculating Market Value		10 days
Warrant | Class A ordinary shares | Maximum
Warrants
Share price		$ 9.20
Public Warrant
Warrants
Minimum threshold written notice period for redemption of public warrants		30 days
Public Warrants exercisable term from the closing of the initial public offering		12 months
Threshold period for filling registration statement after business combination		20 days
Maximum Threshold Period For Registration Statement To Become Effective After Business Combination		60 days
Class of warrant right outstanding		5,375,000
Private Placement Warrant
Warrants
Class of warrant right outstanding		3,150,000

SHAREHOLDERS' EQUITY - Preferen

SHAREHOLDERS' EQUITY - Preference Shares (Details)	Dec. 31, 2020shares
SHAREHOLDERS' EQUITY
Preferred stock, shares authorized	1,000,000
Preferred stock, shares issued	0
Preferred stock, shares outstanding	0

SHAREHOLDERS' EQUITY - Ordinary

SHAREHOLDERS' EQUITY - Ordinary Shares (Details) - $ / shares	Dec. 31, 2020	Aug. 20, 2020	Dec. 31, 2020	Jun. 26, 2020
Common stock, shares subject to forfeiture, as a percent of issued and outstanding shares (as a percent)				20.00%
Class A ordinary shares
Common stock, shares authorized	400,000,000		400,000,000
Common stock, par value	$ 0.0001		$ 0.0001
Common stock, shares issued	2,925,731		2,925,731
Common stock, shares outstanding	2,925,731		2,925,731
Common stock, shares outstanding, subject to possible redemption	21,500,000		21,500,000
Common stock, shares issued, shares subject to possible redemption	21,500,000		21,500,000
Subject to forfeiture (in shares)	20,364,519		20,364,519
Class B ordinary shares
Common stock, shares authorized	10,000,000		10,000,000
Common stock, par value	$ 0.0001		$ 0.0001
Common stock, shares issued	5,375,000	5,750,000	5,375,000
Common stock, shares outstanding	5,375,000	5,750,000	5,375,000
Common Stock, Voting Rights			one
Subject to forfeiture (in shares)		750,000		750,000
Common stock, shares subject to forfeiture, as a percent of issued and outstanding shares (as a percent)		20.00%
Conversion ratio of stock	20.00%
Class B ordinary shares | Sponsor Loan
Forfeiture of founder shares (in shares)		375,000

FAIR VALUE MEASUREMENTS - Finan

FAIR VALUE MEASUREMENTS - Financial Assets Measured at Fair Value (Details) - USD ($)	Dec. 31, 2020	Jun. 23, 2020
Level 3
Financial assets that are measured at fair value
Liabilities measured at fair value	$ 6,615,000	$ 0
Recurring | Level 1
Financial assets that are measured at fair value
Investments held in Trust Account	215,076,225
Recurring | Level 1 | Derivative warrant liabilities | Private Placement Warrant
Financial assets that are measured at fair value
Liabilities measured at fair value	0
Recurring | Level 1 | Derivative warrant liabilities | Public Warrant
Financial assets that are measured at fair value
Liabilities measured at fair value	11,287,500
Recurring | Level 2
Financial assets that are measured at fair value
Investments held in Trust Account	0
Recurring | Level 2 | Derivative warrant liabilities | Private Placement Warrant
Financial assets that are measured at fair value
Liabilities measured at fair value	0
Recurring | Level 2 | Derivative warrant liabilities | Public Warrant
Financial assets that are measured at fair value
Liabilities measured at fair value	0
Recurring | Level 3
Financial assets that are measured at fair value
Investments held in Trust Account	0
Recurring | Level 3 | Derivative warrant liabilities | Private Placement Warrant
Financial assets that are measured at fair value
Liabilities measured at fair value	6,615,000
Recurring | Level 3 | Derivative warrant liabilities | Public Warrant
Financial assets that are measured at fair value
Liabilities measured at fair value	$ 0

FAIR VALUE MEASUREMENTS - Quant

FAIR VALUE MEASUREMENTS - Quantitative Information Regarding Level 3 Fair Value Measurements (Details) - Level 3 - $ / shares	1 Months Ended
	Dec. 31, 2020	Aug. 31, 2020
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Volatility	25.80%	45.00%
Stock price	$ 10.77
Risk-free rate	0.43%	0.35%
Dividend yield	0.00%	0.00%

FAIR VALUE MEASUREMENTS - Chang

FAIR VALUE MEASUREMENTS - Change in Fair Value of Level 3 Fair Value Measurements (Details) - Level 3	6 Months Ended
	Dec. 31, 2020USD ($)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Level 3 Derivative warrant liabilities at June 24, 2020 (inception)	$ 0
Issuance of Public and Private Warrants	16,197,500
Transfer to Level 1 measurement - Public Warrants	(10,212,500)
Change in fair value of derivative warrant liabilities	630,000
Level 3 Derivative warrant liabilities at December 31, 2020	$ 6,615,000

FAIR VALUE MEASUREMENTS - Addit

FAIR VALUE MEASUREMENTS - Additional Information (Details)	6 Months Ended
	Dec. 31, 2020USD ($)
FAIR VALUE MEASUREMENTS
Fair Value Adjustment of Warrants	$ 1,705,000

Quarterly Financial Informati_3

Quarterly Financial Information (Unaudited) - Balance Sheet (Details) - USD ($)	Dec. 31, 2020	Sep. 30, 2020	Aug. 20, 2020	Jun. 23, 2020
BALANCE SHEET
Total assets	$ 216,310,399	$ 216,445,723
Liabilities and Shareholder's Equity
Total current liabilities	140,207	161,956
Deferred legal fees	0	0
Deferred underwriting commissions	7,525,000	7,525,000	$ 7,500,000
Derivative warrant liabilities	17,902,500	16,197,500
Total liabilities	25,567,707	23,884,456
Class A ordinary shares, $0.0001 par value; shares subject to possible redemption	185,742,690
Shareholders' equity
Preference shares - $0.0001 par value	0	0
Additional paid-in capital	7,610,730	5,792,179
Accumulated deficit	(2,611,559)	(792,984)
Total shareholders' equity	5,000,002	5,000,007		$ 0
Total Liabilities and Shareholders' Equity	$ 216,310,399	216,445,723
Class A ordinary shares, par value	$ 0.0001
Preferred stock, par value	$ 0.0001
Class A ordinary shares
Liabilities and Shareholder's Equity
Class A ordinary shares, $0.0001 par value; shares subject to possible redemption		187,561,260
Shareholders' equity
Common stock	$ 293	274
Common shares, par value (in dollars per share)	$ 0.0001
Class B ordinary shares
Shareholders' equity
Common stock	$ 538	538
Common shares, par value (in dollars per share)	$ 0.0001
As Previously Reported
BALANCE SHEET
Total assets	$ 216,310,399	216,445,723
Liabilities and Shareholder's Equity
Total current liabilities	140,207	161,956
Deferred legal fees	0	0
Deferred underwriting commissions	7,525,000	7,525,000
Derivative warrant liabilities	0	0
Total liabilities	7,665,207	7,686,956
Class A ordinary shares, $0.0001 par value; shares subject to possible redemption	203,645,190
Shareholders' equity
Preference shares - $0.0001 par value	0	0
Additional paid-in capital	5,303,949	5,190,381
Accumulated deficit	(304,599)	(191,024)
Total shareholders' equity	5,000,002	5,000,007
Total Liabilities and Shareholders' Equity	$ 216,310,399	$ 216,445,723
Preferred stock, par value	$ 0.0001	$ 0.0001
As Previously Reported | Class A ordinary shares
Liabilities and Shareholder's Equity
Class A ordinary shares, $0.0001 par value; shares subject to possible redemption		$ 203,758,760
Shareholders' equity
Common stock	$ 114	$ 112
Class A ordinary shares, par value	$ 0.0001	$ 0.0001
Common shares, par value (in dollars per share)	$ 0.0001	$ 0.0001
As Previously Reported | Class B ordinary shares
Shareholders' equity
Common stock	$ 538	$ 538
Common shares, par value (in dollars per share)	$ 0.0001	$ 0.0001
Restatement Adjustment
BALANCE SHEET
Total assets	$ 0	$ 0
Liabilities and Shareholder's Equity
Total current liabilities	0	0
Deferred legal fees	0	0
Deferred underwriting commissions	0	0
Derivative warrant liabilities	17,902,500	16,197,500
Total liabilities	17,902,500	16,197,500
Class A ordinary shares, $0.0001 par value; shares subject to possible redemption	(17,902,500)
Shareholders' equity
Preference shares - $0.0001 par value	0	0
Additional paid-in capital	2,306,781	601,798
Accumulated deficit	(2,306,960)	(601,960)
Total shareholders' equity	0	0
Total Liabilities and Shareholders' Equity	0	0
Restatement Adjustment | Class A ordinary shares
Liabilities and Shareholder's Equity
Class A ordinary shares, $0.0001 par value; shares subject to possible redemption		(16,197,500)
Shareholders' equity
Common stock	179	162
Restatement Adjustment | Class B ordinary shares
Shareholders' equity
Common stock	$ 0	$ 0

Quarterly Financial Informati_4

Quarterly Financial Information (Unaudited) - Condensed Statement of Operations (Details) - USD ($)	3 Months Ended	6 Months Ended
	Sep. 30, 2020	Dec. 31, 2020
STATEMENT OF OPERATIONS
Loss from operations	$ (201,002)	$ (380,824)
Other income (expenses)
Change in fair value of derivative warrant liabilities		(1,705,000)
Offering costs associated with derivative warrant liabilities	(601,960)	(601,960)
Net gain from investments held in Trust Account	9,978	76,225
Total other (expense) income	(591,982)	(2,230,735)
Net loss	$ (792,984)	$ (2,611,559)
Class A ordinary shares
Other income (expenses)
Basic and diluted weighted average shares outstanding	21,500,000	21,500,000
Basic and diluted net loss per share	$ 0	$ 0
Class B ordinary shares
Other income (expenses)
Basic and diluted weighted average shares outstanding	5,162,280	5,265,873
Basic and diluted net loss per share	$ (0.16)	$ (0.51)
As Previously Reported
STATEMENT OF OPERATIONS
Loss from operations	$ (201,002)	$ (380,824)
Other income (expenses)
Change in fair value of derivative warrant liabilities		0
Offering costs associated with derivative warrant liabilities		0
Net gain from investments held in Trust Account	9,978	76,225
Total other (expense) income	9,978	76,225
Net loss	$ (191,024)	$ (304,599)
As Previously Reported | Class A ordinary shares
Other income (expenses)
Basic and diluted weighted average shares outstanding	21,500,000	21,500,000
Basic and diluted net loss per share	$ 0	$ 0
As Previously Reported | Class B ordinary shares
Other income (expenses)
Basic and diluted weighted average shares outstanding	5,162,280	5,265,873
Basic and diluted net loss per share	$ (0.04)	$ (0.07)
Restatement Adjustment
STATEMENT OF OPERATIONS
Loss from operations		$ 0
Other income (expenses)
Change in fair value of derivative warrant liabilities		(1,705,000)
Offering costs associated with derivative warrant liabilities	$ (601,960)	(601,960)
Net gain from investments held in Trust Account		0
Total other (expense) income	(601,960)	(2,306,960)
Net loss	$ (601,960)	$ (2,306,960)
Restatement Adjustment | Class A ordinary shares
Other income (expenses)
Basic and diluted weighted average shares outstanding		0
Basic and diluted net loss per share		$ 0
Restatement Adjustment | Class B ordinary shares
Other income (expenses)
Basic and diluted weighted average shares outstanding		0
Basic and diluted net loss per share		$ 0

Quarterly Financial Informati_5

Quarterly Financial Information (Unaudited) - Condensed Statement of Cash Flows (Details) - USD ($)	3 Months Ended	6 Months Ended
	Sep. 30, 2020	Dec. 31, 2020
STATEMENT OF CASH FLOWS
Net loss	$ (792,984)	$ (2,611,559)
Offering costs associated with derivative warrant liabilities	601,960	601,960
Net cash used in operating activities	(393,915)	(614,968)
Net cash used in investing activities	(215,000,000)	(215,000,000)
Net cash provided by financing activities	216,459,791	216,534,791
Net change in cash	1,065,876	919,823
As Previously Reported
STATEMENT OF CASH FLOWS
Net loss	(191,024)	(304,599)
Offering costs associated with derivative warrant liabilities		0
Net cash used in operating activities	(393,915)	(614,968)
Net cash used in investing activities	(215,000,000)	(215,000,000)
Net cash provided by financing activities	216,459,791	216,534,791
Net change in cash	1,065,876	919,823
Restatement Adjustment
STATEMENT OF CASH FLOWS
Net loss	(601,960)	(2,306,960)
Offering costs associated with derivative warrant liabilities	601,960	601,960
Net cash used in operating activities	0	0
Net cash used in investing activities	0	0
Net cash provided by financing activities	0	0
Net change in cash	$ 0	$ 0

SUBSEQUENT EVENTS (Details)

SUBSEQUENT EVENTS (Details)	Feb. 23, 2021USD ($)$ / sharesshares	Dec. 31, 2020$ / shares
Class A ordinary shares
Subsequent Event [Line Items]
Common stock, par value		$ 0.0001
Class B ordinary shares
Subsequent Event [Line Items]
Common stock, par value		$ 0.0001
Subsequent event
Subsequent Event [Line Items]
Exchange ratio, numerator used for determination | $	$ 1,700,000,000
Consideration in shares for business combination, denominator used for determination	$ 10
Number of earnout shares | shares	14,666,667
Threshold tangible assets | $	$ 5,000,001
Subsequent event | After domestication
Subsequent Event [Line Items]
Number of shares in each Domesticated Unit | shares	1
Number of warrants in each Domesticated Unit | shares	1
Number of shares called by each warrant | shares	1
Subsequent event | Volume-weighted average price atleast 12.50
Subsequent Event [Line Items]
Volume-weighted average share price	$ 12.50
Number of consecutive trading days to calculate VWAPs	30
Number of trading days to calculate VWAPs	20
Number of earn out shares issued | shares	8,000,000
Subsequent event | Volume-weighted average price atleast 15.00
Subsequent Event [Line Items]
Volume-weighted average share price	$ 15
Number of consecutive trading days to calculate VWAPs	30
Number of trading days to calculate VWAPs	20
Number of earn out shares issued | shares	6,666,667
Subsequent event | Class A ordinary shares
Subsequent Event [Line Items]
Common stock, par value	$ 0.0001
Subsequent event | Class B ordinary shares
Subsequent Event [Line Items]
Common stock, par value	0.0001
Subsequent event | Markforged
Subsequent Event [Line Items]
Common stock, par value	$ 0.0001
Subsequent event | Markforged | Maximum
Subsequent Event [Line Items]
Share repurchase value | $	$ 45,000,000